Friday, June 17, 2016

BRIEF-Ariad Pharmaceuticals completes strategic review, reaffirms 2016 outlook

* Outcomes of strategic review includes significant

reduction in company's expense base

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)